Search Results - "Ribera, José María"

Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival by LAHUERTA, Juan José, MATEOS, Maria Victoria, BESALDUCH, Joan, DE ARRIBA, Felipe, RIBERA, José Maria, ESCODA, Lourdes, HERNDNDEZ-RUIZ, Belén, GARCIA-FRADE, Javier, RIVAS-GONZALEZ, Concepcion, ALEGRE, Adrian, BLADE, Joan, SAN MIGUEL, Jesus F, MARTINEZ-LOPEZ, Joaquin, ROSINOL, Laura, SUREDA, Anna, DE LA RUBIA, Javier, GARCIA-LARANA, José, MARTINEZ-MARTINEZ, Rafael, HERNANDEZ-GARCIA, Miguel T, CARRERA, Dolores

“…Complete response (CR) is considered an important goal in most hematologic malignancies. However, in multiple myeloma (MM), there is no consensus regarding…”
Get full text

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome by Muñiz, Carmen, Martín-Martín, Lourdes, López, Antonio, Sánchez-González, Blanca, Salar, Antonio, Almeida, Julia, Sancho, Juan-Manuel, Ribera, José María, Heras, Cecilia, Peñalver, Francisco Javier, Gómez, Marta, González-Barca, Eva, Alonso, Natalia, Navarro, Belén, Olave, Teresa, Sala, Francisco, Conde, Eulogio, Márquez, José Antonio, Cabezudo, Elena, Cladera, Antonia, García-Malo, María, Caballero, María Dolores, Orfao, Alberto

“…Flow cytometry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma; however, some FCM-negative patients show…”
Get full text

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA by Pagano, Livio, Salmanton-García, Jon, Marchesi, Francesco, López-García, Alberto, Lamure, Sylvain, Itri, Federico, Gomes-Silva, Maria, Dragonetti, Giulia, Falces-Romero, Iker, van Doesum, Jaap, Sili, Uluhan, Labrador, Jorge, Calbacho, Maria, Bilgin, Yavuz M., Weinbergerová, Barbora, Serrano, Laura, Ribera-Santa Susana, José-María, Malak, Sandra, Loureiro-Amigo, José, Glenthøj, Andreas, Córdoba-Mascuñano, Raúl, Nunes-Rodrigues, Raquel, González-López, Tomás-José, Karlsson, Linda Katharina, Jiménez-Lorenzo, María-Josefa, Hernández-Rivas, José-Ángel, Jaksic, Ozren, Ráčil, Zdeněk, Busca, Alessandro, Corradini, Paolo, Hoenigl, Martin, Klimko, Nikolai, Koehler, Philipp, Pagliuca, Antonio, Passamonti, Francesco, Cornely, Oliver A.

“…In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients…”
Get full text

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia by Buatois, Vanessa, Johnson, Zoë, Salgado-Pires, Susana, Papaioannou, Anne, Hatterer, Eric, Chauchet, Xavier, Richard, Françoise, Barba, Leticia, Daubeuf, Bruno, Cons, Laura, Broyer, Lucile, D'Asaro, Matilde, Matthes, Thomas, LeGallou, Simon, Fest, Thierry, Tarte, Karin, Clarke Hinojosa, Robert K, Genescà Ferrer, Eulàlia, Ribera, José María, Dey, Aditi, Bailey, Katharine, Fielding, Adele K, Eissenberg, Linda, Ritchey, Julie, Rettig, Michael, DiPersio, John F, Kosco-Vilbois, Marie H, Masternak, Krzysztof, Fischer, Nicolas, Shang, Limin, Ferlin, Walter G

“…CD47, an ubiquitously expressed innate immune checkpoint receptor that serves as a universal "don't eat me" signal of phagocytosis, is often upregulated by…”
Get full text

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial by Mateos, María-Victoria, Dr, Oriol, Albert, MD, Martínez-López, Joaquín, MD, Gutiérrez, Norma, MD, Teruel, Ana-Isabel, MD, de Paz, Raquel, MD, García-Laraña, José, MD, Bengoechea, Enrique, MD, Martín, Alejandro, MD, Mediavilla, Joaquín Díaz, MD, Palomera, Luis, MD, de Arriba, Felipe, MD, González, Yolanda, MD, Hernández, Jose-Mariano, MD, Sureda, Ana, MD, Bello, José-Luis, MD, Bargay, Joan, MD, Peñalver, Francisco-Javier, MD, Ribera, José-María, MD, Martín-Mateos, María-Luisa, MD, García-Sanz, Ramón, MD, Cibeira, María-Teresa, MD, Ramos, María-Luisa Martín, MD, Vidriales, María-Belén, MD, Paiva, Bruno, MD, Montalbán, María-Angeles, MD, Lahuerta, Juan-José, MD, Bladé, Joan, MD, Miguel, Jesús-Fernando San, Prof

“…Summary Background Bortezomib plus melphalan and prednisone (VMP) is significantly better than melphalan plus prednisone alone for elderly patients with…”
Get full text

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial by Mateos, María-Victoria, Oriol, Albert, Martínez-López, Joaquín, Gutiérrez, Norma, Teruel, Ana-Isabel, López de la Guía, Ana, López, Javier, Bengoechea, Enrique, Pérez, Montserrat, Polo, Marta, Palomera, Luis, de Arriba, Felipe, González, Yolanda, Hernández, Jose-Mariano, Granell, Miquel, Bello, José-Luis, Bargay, Joan, Peñalver, Francisco-Javier, Ribera, José-María, Martín-Mateos, María-Luisa, García-Sanz, Ramón, Lahuerta, Juan-José, Bladé, Joan, San-Miguel, Jesús F.

“…Maintenance therapy has become a hot field in myeloma, and it may be particularly relevant in elderly patients because the major benefit results from the…”
Get full text

Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease by Gonzalez-Barca, Eva, Domingo-Domenech, Eva, Capote, Francisco Javier, Gomez-Codina, Jose, Salar, Antonio, Bailen, Alicia, Ribera, Jose-Maria, Lopez, Andres, Briones, Javier, Munoz, Andres, Encuentra, Maite, Fernandez de Sevilla, Alberto, on behalf of GEL/TAMO (Grupo Espanol de Linfomas), GELCAB (Grupo para el Estudio de los Linfomas Catalano-Balear) and GOTEL (Grupo Oncologico para el Tratamiento y Estudio de los Linfomas)

“…Hematology Department, Hospital Duran I Reynals, Institut Catalá d’ Oncología, L’Hospitalet de Llobregat, Barcelona, Spain (EDD); Hematology Department…”
Get full text

Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients by Piñana, José Luis, Vázquez, Lourdes, Martino, Rodrigo, de la Cámara, Rafael, Sureda, Anna, Rodríguez-Veiga, Rebeca, Garrido, Ana, Sierra, Jorge, Ribera, José-María, Torrent, Anna, Mateos, María Victoria, de la Rubia, Javier, Tormo, Mar, Díez-Campelo, María, García-Gutiérrez, Valentín, Álvarez-Larrán, Alberto, Sancho, Juan-Manuel, MartínGarcía-Sancho, Alejandro, Yañez, Lucrecia, Pérez Simón, José Antonio, Barba, Pere, Abrisqueta, Pau, Álvarez-Twose, Iván, Bonanad, Santiago, Lecumberri, Ramón, Ruiz-Camps, Isabel, Navarro, David, Hernández-Rivas, José-Ángel, Cedillo, Ángel, García-Sanz, Ramón, Bosch, Francesc

“…In the midst of the COVID-19 pandemic, different vaccines in front of SARS-CoV-2 have been approved and administered in different vulnerable populations. As…”
Get full text

Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab by Ribera, Jose-Maria, Genescà, Eulalia, Ribera, Jordi

“…Bispecific T-cell engaging antibodies are constructs engineered to bind to two different antigens, one to a tumor-specific target and the other to CD3-positive…”
Get full text

Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid by Sanchez, Ricardo, Ayala, Rosa, Alonso, Rafael Alberto, Martínez, María Pilar, Ribera, Jordi, García, Olga, Sanchez-Pina, José, Mercadal, Santiago, Montesinos, Pau, Martino, Rodrigo, Barba, Pere, González-Campos, José, Barrios, Manuel, Lavilla, Esperanza, Gil, Cristina, Bernal, Teresa, Escoda, Lourdes, Abella, Eugenia, Amigo, Ma Luz, Moreno, Ma José, Bravo, Pilar, Guàrdia, Ramón, Hernández-Rivas, Jesús-María, García-Guiñón, Antoni, Piernas, Sonia, Ribera, José-María, Martínez-López, Joaquín

“…We investigated the frequency, predictors, and evolution of acute lymphoblastic leukemia (ALL) in patients with CNS relapse and introduced a novel method for…”
Get full text

The EHA Research Roadmap: Malignant Lymphoid Diseases by Dreyling, Martin, André, Marc, Gökbuget, Nicola, Tilly, Hervé, Jerkeman, Mats, Gribben, John, Ferreri, Andrés, Morel, Pierre, Stilgenbauer, Stephan, Fox, Christopher, Maria Ribera, José, Zweegman, Sonja, Aurer, Igor, Bödör, Csaba, Burkhardt, Birgit, Buske, Christian, Dollores Caballero, Maria, Campo, Elias, Chapuy, Bjoern, Davies, Andrew, Leval, Laurence, Doorduijn, Jeanette, Federico, Massimo, Gaulard, Philippe, Gay, Francesca, Ghia, Paolo, Grønbæk, Kirsten, Goldschmidt, Hartmut, Kersten, Marie‐Jose, Kiesewetter, Barbara, Landman‐Parker, Judith, Le Gouill, Steven, Lenz, Georg, Leppä, Sirpa, Lopez‐Guillermo, Armando, Macintyre, Elizabeth, Mantega, Maria Victoria Mateos, Moreau, Philippe, Moreno, Carol, Nadel, Bertrand, Okosun, Jessica, Owen, Roger, Pospisilova, Sarka, Pott, Christiane, Robak, Tadeusz, Spina, Michelle, Stamatopoulos, Kostas, Stary, Jan, Tarte, Karin, Tedeschi, Allessandra, Thieblemont, Catherine, Trappe, Ralf Ulrich, Trümper, Lorenz H., Salles, Gilles

“…In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the…”
Get full text

Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse by Forero-Castro, Maribel, Montaño, Adrián, Robledo, Cristina, García de Coca, Alfonso, Fuster, José Luis, de las Heras, Natalia, Queizán, José Antonio, Hernández-Sánchez, María, Corchete-Sánchez, Luis A., Martín-Izquierdo, Marta, Ribera, Jordi, Ribera, José-María, Benito, Rocío, Hernández-Rivas, Jesús M.

“…The clonal basis of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is complex and not fully understood. Next-generation sequencing (NGS),…”
Get full text

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia by Piñana, José Luis, Sanz, Jaime, Picardi, Alessandra, Ferrá, Christelle, Martino, Rodrigo, Barba, Pere, Gonzalez-Vicent, Marta, Pascual, María Jesús, Martín, Carmen, Verdeguer, Amparo, de Heredia, Cristina Diaz, Montesinos, Pau, Ribera, José-María, Sanz, Miguel, Arcese, William, Sanz, Guillermo

“…There are very few disease-specific studies focusing on outcomes of umbilical cord blood transplantation for Philadelphia chromosome-positive acute…”
Get full text

Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors by Miralles, Pilar, Berenguer, Juan, Ribera, José María, Rubio, Rafael, Mahillo, Beatriz, Téllez, María Jesús, Lacruz, José, Valencia, Eulalia, Santos, Jesús, Rodríguez-Arrondo, Francisco, Pintado, Vicente

“…OBJECTIVES:To assess complete remission (CR) and survival in patients with systemic AIDS-related non-Hodgkin lymphoma (ARL) receiving highly active…”
Get full text

Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy by Berenguer, Juan, Miralles, Pilar, Ribera, José María, Rubio, Rafael, Valencia, Eulalia, Mahillo, Beatriz, Pintado, Vicente, Palacios, Rosario, Montes, María Luisa, Téllez, María Jesús, La Cruz, José, Torre-Cisneros, Julián, Rodríguez-Arrondo, Francisco, Sepúlveda, María Antonia, Gutiérrez, Félix, Peralta, Galo, Boix, Vicente

“…OBJECTIVES:We analyzed survival, therapeutic response, and prognostic factors in patients with HIV-related Hodgkin lymphoma (HL) treated or not with highly…”
Get full text

Myeloproliferative disease in two young siblings by Cervantes, F, Ribera, J M, Sanchez-Bisono, J, Brugues, R, Rozman, C

“…Two siblings developed a myeloproliferative disease. One of them was a 9-year-old girl with a short history of bleeding, whose initial clinical and hematologic…”
Get more information

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma by Kwon, Mi, Iacoboni, Gloria, Reguera, Juan Luis, Corral, Lucía López, Morales, Rafael Hernani, Ortiz-Maldonado, Valentín, Guerreiro, Manuel, Caballero, Ana Carolina, Domínguez, María Luisa Guerra, Pina, Jose Maria Sanchez, Mussetti, Alberto, Sancho, Juan Manuel, Bastos-Oreiro, Mariana, Catala, Eva, Delgado, Javier, Henriquez, Hugo Luzardo, Sanz, Jaime, Calbacho, María, Bailén, Rebeca, Carpio, Cecilia, Ribera, Jose Maria, Sureda, Anna, Briones, Javier, Hernandez-Boluda, Juan Carlos, Cebrián, Nuria Martínez, Martin, Jose Luis Diez, Martín, Alejandro, Barba, Pere

“…Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CD19-targeted chimeric antigen receptor (CAR) T cells approved for relapsed/refractory…”
Get full text

Study of effectiveness of 3 schedules of administration of erythropoietic colony-stimulating factors in anemic patients under chemotherapy for solid or hematology malignancy by Pontón Sivillá, José Luis, Feliu Frasnedo, Evaristo, Modamio Charles, Pilar, Mariño Hernández, Eduardo L, Font Pous, Albert, Lezcano Rubio, Clara, Ribera Santasusana, José María, Bonafont Pujol, Xavier

“…The treatment of chemotherapy associated anemia in patients with cancer has varied greatly in recent years. The objective of this study was to verify whether…”
Get more information

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies by de Lima, Marcos, Di Rocco, Alice, Ribera, Jose-Maria

Get full text

Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial by Jabbour, Elias, Kantarjian, Hagop M, Aldoss, Ibrahim, Montesinos, Pau, Leonard, Jessica T, Gómez-Almaguer, David, Baer, Maria R, Gambacorti-Passerini, Carlo, McCloskey, James, Minami, Yosuke, Papayannidis, Cristina, Rocha, Vanderson, Rousselot, Philippe, Vachhani, Pankit, Wang, Eunice S, Wang, Bingxia, Hennessy, Meliessa, Vorog, Alexander, Patel, Niti, Yeh, Tammie, Ribera, Jose-Maria

“…IMPORTANCE: In newly diagnosed Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL), disease progression due to acquired resistance to…”
Get full text